Table:
begin	end	state
1	49	cytoplasmic
50	72	transmembrane
73	105	non-cytoplasmic
106	131	transmembrane
132	191	cytoplasmic
192	212	transmembrane
213	216	non-cytoplasmic
217	236	transmembrane
237	287	cytoplasmic
288	312	transmembrane
313	313	non-cytoplasmic
314	325	transmembrane
326	329	non-cytoplasmic
330	351	transmembrane
352	622	cytoplasmic

Input:
>WP_109967879.1 NCBI__GCF_003173355.1:WP_109967879.1
MTSQSGPIGKIPLRGRLRLLRDSLTYVPPGKDGEFKYRDILYFTRYLIPLKYAIISSLIL
TFISSLLGTALPLSGKWIIDYIFMHQSIEPVLDRLSAHHLAFLVPFASQVFSSLPLLIGT
LAVVSIVKYLIGNELSLINYRINTEYGYRVKMAVFTHVMKYPVSFFKSTRSGYLLARISS
DTAGLSGISGSFLQNIITAGTSLCVTATVLSALSLPLTLFVIITVPVSVIISYWVVRFTR
SYSIRMRESGLQMAADGQDLFSSIDLIKTHAAEERELNRYMKRTLDNISLNIASMLFGQV
TGGVQMAFTNIVRLIVMLYGGSLVLSNQMSIGSYTAFLAMYPQLTGAISTFLQMPLNLQG
TALAAGRVKELLDMTTEYEHDDPKKTLLYPDIRTNGHIIVDCVSFSYDPDTPVLKDVSLE
IQPGDRIGLIGQTGAGKTTFINLLLKFYRPNQGKILIDDYDYADLNPAWIRNQIAVVSQD
LMLFHDTVMNNIRYSRPEADDEEVMRAAQSAGIHDEIIRLQNGYDTIVGERGSKLSGGQK
QRIAIARAFLRNAQIVILDEPTAHLDIETEELLIREFISVCSGRTMVVITHRESLLRLVD
RVYRLKKGKIHEEKRDASLISA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server